Describe the 5-year survival rate following treatment.
ALL: The 5-year survival rate is generally higher compared to AML (varies from ∼ 20% in elderly patients to ∼ 80% in children and adolescents)
AML: ∼ 30%, but it varies according to the patient's age. The survival time has increased more recently due to improvements in treatment.
Unfavorable prognostic factors.
Favorable prognostic factors.
Zuletzt geändertvor 2 Jahren
